Radiopharmaceuticals: all 1,299 studies that test it

Page 5 of 13. Open to participants first (296), then studies with results posted, then the rest; newest registration first within each.

• Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1TerminatedNCT03007719Phase 2Results posted
• Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99MoTerminatedNCT03002454Phase 3Results posted
• Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate CancerCompletedNCT02981368Phase 2/3Results posted
• Study Testing Radium-223 Dichloride in Relapsed Multiple MyelomaTerminatedNCT02928029Phase 1/2Results posted
• Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy PatientsCompletedNCT02919111Phase 2/3Results posted
• Gallium-68 PSMA-11 PET in Patients With Biochemical RecurrenceCompletedNCT02918357Phase 2/3Results posted
• Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)CompletedNCT02903160Phase 2Results posted
• Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RACompletedNCT02865434Phase 1/2Results posted
• 11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced NeuroinflammationTerminatedNCT02811744Phase 2Results posted
• Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05CompletedNCT02795780Phase 2Results posted
• Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal DementiaCompletedNCT02736695Phase 1Results posted
• [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver CancerCompletedNCT02695628Phase 2Results posted
• Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell CarcinomaCompletedNCT02687139Not applicableResults posted
• Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer PatientsCompletedNCT02683083Phase 1Results posted
• Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With ADCompletedNCT02681172Phase 4Results posted
• 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer TreatmentCompletedNCT02680041Phase 3Results posted
• 68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing SurgeryCompletedNCT02678351Phase 2/3Results posted
• Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT MutationsCompletedNCT02676843Phase 2Results posted
• 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial TreatmentCompletedNCT02673151Phase 2/3Results posted
• Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)CompletedNCT02658968Phase 1Results posted
• 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate CancerCompletedNCT02624518Phase 2/3Results posted
• Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer PatientsCompletedNCT02611882Phase 2Results posted
• 18F-FSPG PET/CT for Cancer Patients on TherapyCompletedNCT02599194Phase 2Results posted
• Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based ChemotherapyCompletedNCT02569723Not applicableResults posted
• 11C-acetate for Treatment Response After Radiotherapy for HCCTerminatedNCT02549755Phase 2Results posted
• Somatostatin Receptor Imaging in Patients With Suspected Cardiac SarcoidosisCompletedNCT02546388Not applicableResults posted
• SLM + Axitinib for Clear Cell RCCCompletedNCT02535533Phase 1/2Results posted
• Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical ProstatectomyCompletedNCT02523924Not applicableResults posted
• 18F-AV-1451 Autopsy StudyCompletedNCT02516046Phase 3Results posted
• A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node MappingCompletedNCT02509598Phase 2Results posted
• A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node DissectionTerminatedNCT02509585Phase 2Results posted
• 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate CancerCompletedNCT02488070Phase 1/2Results posted
• 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary NodulesCompletedNCT02448225Phase 2Results posted
• 68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate CancerCompletedNCT02440308Phase 2Results posted
• 11C- and 18F-Choline PET/MR Imaging for Prostate CancerCompletedNCT02397408Phase 2Results posted
• Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast CancerCompletedNCT02366130Phase 2Results posted
• 18F-AV-1451 High Resolution Autopsy StudyCompletedNCT02350634Phase 1Results posted
• A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate CancerCompletedNCT02346526Phase 2Results posted
• Augmenting Flortaucipir Dosimetry EstimatesCompletedNCT02336360Phase 1Results posted
• Sentinel Lymph Node Biopsy Findings in Patients With Breast CancerCompletedNCT02287675Phase 4Results posted
• BrUOG L301 With Non-Small Cell Lung Cancer and Bone MetastasesCompletedNCT02283749Phase 2Results posted
• Clinical Evaluation of Flortaucipir F 18CompletedNCT02278367Phase 2Results posted
• Tau Imaging in Professional FightersCompletedNCT02278354Phase 1Results posted
• Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast CancerTerminatedNCT02258464Phase 2Results posted
• Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast CancerCompletedNCT02258451Phase 2Results posted
• Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell MassCompletedNCT02236754Early Phase 1Results posted
• Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CTCompletedNCT02201420Phase 2Results posted
• Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate CancerCompletedNCT02199197Phase 2Results posted
• GA-68 DOTA-TOC of Somatostatin Positive MalignanciesTerminatedNCT02177773Phase 1/2Results posted
• 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent GliomasTerminatedNCT02175745Not applicableResults posted
• Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy VolunteersCompletedNCT02167594Phase 1Results posted
• F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyTerminatedNCT02149173Not applicableResults posted
• Radium 223 in Castrate Resistant Prostate Cancer Bone MetastasesCompletedNCT02135484Not applicableResults posted
• Florbetapir Calibration to the Centiloid ScaleCompletedNCT02120664Phase 1Results posted
• The Feasibility of Florbetapir Quantitation in EuropeCompletedNCT02107599Phase 4Results posted
• Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone MetastasisCompletedNCT02097303Phase 2Results posted
• 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic EncephalopathyCompletedNCT02079766Phase 2Results posted
• Evaluation of Reader Training ProcessesCompletedNCT02051790Phase 4Results posted
• Imaging Characteristics of a Follow-up 18F-AV-1451 ScanTerminatedNCT02051764Phase 2Results posted
• A Phase I/II Study of [124I]mIBG PET/CT in NeuroblastomaCompletedNCT02043899Phase 1/2Results posted
• Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild SymptomsCompletedNCT02043678Phase 3Results posted
• Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the BoneCompletedNCT02023697Phase 2Results posted
• Monoamine Contributions to Neurocircuitry in Eating DisordersCompletedNCT02020408Phase 4Results posted
• Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) PatientsCompletedNCT02016872Not applicableResults posted
• Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD SubjectsCompletedNCT02016560Phase 2/3Results posted
• A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired SubjectsCompletedNCT01992380Phase 1Results posted
• 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation TherapyCompletedNCT01991977Phase 2Results posted
• The Feasibility of Florbetapir QuantitationCompletedNCT01946243Phase 4Results posted
• Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.CompletedNCT01936649Phase 4Results posted
• Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone MetastasesCompletedNCT01934790Phase 1/2Results posted
• FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerCompletedNCT01928186Not applicableResults posted
• 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary HypertensionCompletedNCT01917136Phase 2Results posted
• Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.CompletedNCT01890343Phase 2Results posted
• Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk OsteosarcomaTerminatedNCT01886105Phase 2Results posted
• Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CTCompletedNCT01869725Phase 2Results posted
• Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOPCompletedNCT01868035Phase 2Results posted
• Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in OsteosarcomaCompletedNCT01833520Phase 1/2Results posted
• Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate CancerCompletedNCT01815515Phase 1/2Results posted
• FACBC for Recurrent Prostate CancerCompletedNCT01808222Phase 2Results posted
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
• Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck CancerCompletedNCT01774760Phase 2Results posted
• Study of 89Zr-DFO-MSTP2109A in Patients With Prostate CancerCompletedNCT01774071Phase 1/2Results posted
• Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS PatientsCompletedNCT01767493Phase 4Results posted
• [F-18] Fluorothymidine PET/CT Imaging for Pelvic CancersCompletedNCT01717391Phase 2Results posted
• Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive DeclineCompletedNCT01703702Phase 4Results posted
• Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation TherapyTerminatedNCT01682031Phase 2Results posted
• Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid MalignanciesTerminatedNCT01678443Phase 1Results posted
• Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) ImagesCompletedNCT01672827Phase 3Results posted
• A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to HistopathologyCompletedNCT01667536Phase 2Results posted
• FACBC Outcomes for Post ProstatectomyCompletedNCT01666808Phase 2/3Results posted
• A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)CompletedNCT01662882Phase 2/3Results posted
• Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)TerminatedNCT01662102Phase 3Results posted
• A Study of Florbetapir (18F) in Japanese Healthy VolunteersCompletedNCT01660815Phase 1Results posted
• Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)CompletedNCT01607476Phase 2Results posted
• A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid TumoursCompletedNCT01578239Phase 3Results posted
• Anti-3-[18F]FACBC Imaging of Parathyroid AdenomasCompletedNCT01574287Not applicableResults posted
• Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)CompletedNCT01565382Phase 3Results posted
• Evaluation of Physician Training Methods to Read Florbetapir-PET ScansCompletedNCT01565369Not applicableResults posted
• Evaluation of PET Scan Timing Relative to AV-45 Injection TimeCompletedNCT01565356Not applicableResults posted
• A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy VolunteersCompletedNCT01565343Phase 1Results posted

← Radiopharmaceuticals overview